Patient info

Lotriderm cream – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
Prescription only (POM)
Medicine strength:
640 microgram/gram + 10 mg/gram
Contains active substances:
Similar medicines:

Patient leaflet - Lotriderm cream

What Lotriderm Cream is and what it is used for

Lotriderm Cream contains the active ingredients 0.064% w/w betamethasone dipropionate (equivalent to 0.05 % w/w betamethasone) and 1.0% w/w clotrimazole. Betamethasone belongs to a group of medicines called topical corticosteroids which are used on the surface of the skin to reduce the redness and itchiness caused by certain skin problems. Clotrimazole is a topical anti-fungal medicine used to treat some fungal infections of the skin.

Lotriderm Cream is used for the short-term treatment of certain fungal infections of the skin, when redness and itchiness may also be a problem.

What you need to know before you use Lotriderm Cream

Do not use Lotriderm Cream

  • if you are allergic to betamethasone dipropionate, clotrimazole or any of the other ingredients of this medicine (listed in section 6).
  • if your skin becomes irritated, or you develop an allergic reaction.
  • on any other skin infections as it could make them worse, especially rosacea (a skin condition affecting the face), acne, dermatitis (skin inflammation) around the mouth, nappy rash or other skin infections.

Warnings and precautions

If you have psoriasis, your doctor may want to review your treatment regularly. Contact your doctor if your psoriasis gets worse or you get raised bumps filled with pus under your skin.

Contact your doctor immediately if you, or your child, experience blurred vision or other visual disturbances.

Side effects that may happen with inhaled or oral corticosteroids may also occur with corticosteroids used on the skin, especially in infants and children. If you use more than the correct amount of cream and/or use it for longer than is recommended, it can affect the levels of certain hormones in the body, particularly in infants and children.

In adults the changes in hormone levels may lead rarely to puffiness or rounding of the face, weakness, tiredness, and dizziness when standing or sitting down.

Children

Do not use this medicine on children under 12 years of age unless advised by your doctor.

If you use more than the correct amount of cream and/or use it for longer than is recommended, it can affect your child’s hormones. Rarely this may lead to:

  • Delayed growth and development
  • A moon face or rounding of the face
  • A build-up of pressure around the brain which can produce

    • a bulging of the fontanelle (the soft spot in the top of the skull) in infants
    • a constant thumping headache
    • blurred vision or other visual disturbances

Other medicines and Lotriderm Cream Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Lotriderm Cream contains

  • cetostearyl alcohol, which may cause localised skin reactions (e.g. contact dermatitis).

  • 100mg propylene glycol in each gram, which may cause skin irritation. Because this medicine contains propylene glycol, do not use it on open wounds or large areas of broken or damaged skin (such as burns) without checking with your doctor or pharmacist.
  • 10mg benzyl alcohol in each gram, which may cause allergic reactions or mild local irritation.

How to use Lotriderm Cream

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • For adults and children over the age of 12 years a layer of cream should be gently massaged into the affected and surrounding skin areas twice a day, in the morning and evening.
  • Usually the cream should be used for either two weeks or four weeks, depending on the type of infection you have.

Patient Information Leaflet (betamethasone dipropionate/clotrimazole)

Lotriderm Cream

®

1

6

4

5

2

3

1

2

3

Ref: 1113/150424/1/F

  • Your doctor will tell you how long to use the cream for. Your skin infection should start to improve and the redness and itchiness will ease within the first few days of treatment.
  • If your skin infection does not appear to get any better, you should see your doctor.

You should always follow these instructions when using Lotriderm Cream:

  • Keep the cream away from your eyes.
  • If Lotriderm Cream is used in children, it should not be used on any part of their body for more than 5 days.
  • Do not put the cream under a dressing, such as a plaster or bandage, as this makes it easier for the active ingredient of the medicine to pass through the skin and possibly cause some unwanted effects.
  • You must not use a large amount of cream on large areas of the body for a long time (for example every day for many weeks or months).
  • Do not apply the cream to the face for more than 5 days, in places where the skin folds (e.g. the back of the knee) or on large areas of damaged skin.

If you use more Lotriderm Cream than you should

Tell your doctor if:

  • you (or someone else) accidentally swallows the cream, it should not produce any undesirable effects.
  • you use the cream more often than you should, or on large areas of the body, it may cause some side effects.
  • you have not followed the dosage instructions, or your doctor’s advice and have used the cream too frequently and/or for a long time

If you forget to use Lotriderm Cream If you forget to use your cream at the right time, use it as soon as you remember, then carry on as before.

Possible side effects

A few people may find that they suffer from some of the following side effects after using Lotriderm Cream:

  • burning and stinging
  • rash; swelling and other skin infections.

In addition, the following side effects have been reported to occur following the use of other medicines containing either clotrimazole or betamethasone dipropionate:

  • redness, stinging, blistering, peeling, swelling, itching, burning, skin rash, dryness of the skin
  • inflammation of the hair follicles; excessive hair growth
  • darkening of the skin; allergic skin reactions; dermatitis (skin inflammation) around the mouth; other skin infections, thinning of the skin and red marks.
  • blurred vision.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

How to store Lotriderm Cream

EXPIRY DATE

Do not use this medicine after the expiry date shown on the carton label or tube. Only keep this medicine if your doctor tells you to. If your cream becomes discoloured or shows any other signs of deterioration, consult your pharmacist (chemist) who will tell you what to do.

You should return any left over cream to your pharmacist.

HOW TO STORE

  • Do not store above 25°C
  • Keep this medicine out of the sight and reach of children

IMPORTANT

Remember this medicine is for you it can only be prescribed by a doctor. Never give your medicine to other people it may harm them, even if their symptoms are the same. This leaflet does not tell you everything about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist (chemist). He/she will have additional information about this medicine and will be able to advise you.

Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Contents of the pack and other information

What Lotriderm Cream contains

Lotriderm Cream contains 0.064% w/w betamethasone dipropionate and 1.0% w/w clotrimazole, as well as the following inactive ingredients: liquid paraffin; white soft paraffin; cetostearyl alcohol; macrogol cetostearyl ether; benzyl alcohol; sodium dihydrogen phosphate dihydrate; phosphoric acid concentrated; sodium hydroxide; propylene glycol; purified water.

What Lotriderm Cream looks like and contents of the pack

Lotriderm Cream is a white cream.

Lotriderm Cream is available in tubes of 30g.

Manufacturer and Licence Holder

Lotriderm Cream is manufactured by Organon Heist bv, Industriepark 30, B-2220 Heist-op-den-Berg, Belgium and is procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Limited, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE

PL 15184/1113

Leaflet revision date: 15/04/24

Lotriderm is a registered trademark of N.V. Organon.

Blind or partially sighted? Is this leaflet hard to see or read? Phone Lexon (UK) Limited, Tel:

01527 505414 to obtain the leaflet in a format suitable for you

6

4

Ref: 1113/150424/1/B POM

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 15184/1113

Last revision stated in the text: 15 April 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lotriderm cream

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Betamethasone, Clotrimazole
Strength 640 microgram/gram + 10 mg/gram
Pharmaceutical form Cutaneous cream
How is it taken Cutaneous
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. D Dermatologicals
    1. D07 Corticosteroids, dermatological preparations
      1. D07C Corticosteroids, combinations with antibiotics
        1. D07CC Corticosteroids, potent, combinations with antibiotics
          1. D07CC01 betamethasone and antibiotics
Marketing authorisation PLPI 15184/1113
Codes BNF 13040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.